<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3131">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04363606</url>
  </required_header>
  <id_info>
    <org_study_id>20CH085</org_study_id>
    <secondary_id>2020-A00982-37</secondary_id>
    <nct_id>NCT04363606</nct_id>
  </id_info>
  <brief_title>Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability</brief_title>
  <acronym>FatCovid-19</acronym>
  <official_title>Chronic Fatigue Etiology and Recovery in Covid-19 Patients in Intensive Care Unit : the Role of Fatigability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Saint-Etienne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic fatigue is the most common and debilitating symptom in intensive care unit (ICU)
      survivors. Indeed, it has been widely reported that patients who stayed in ICU for prolonged
      periods report a feeling of tiredness for months to years after ICU discharge. This symptom
      seems particularly pronounced in Covid-19 patients and may affect their quality of life by
      decreasing their capacity to perform simple tasks of daily life.

      The aim of the present project is to determine whether deteriorated neuromuscular function
      (i.e. increased fatigability) is involved in the feeling of fatigue of Covid-19 patients.
      Because the causes of this feeling are multi-dimensional, a large battery of tests will allow
      us to better understand the origin of chronic fatigue. A better knowledge of chronic fatigue
      etiology and its recovery will allow to optimize rehabilitation treatments to shorten the
      persistence of chronic fatigue and in fine improve life quality.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 27, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>voluntary maximum force reduction</measure>
    <time_frame>6 weeks post-discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neuromuscular function : cortical activity</measure>
    <time_frame>6 weeks post-discharge</time_frame>
    <description>Level of cortical activation and cortico-spinal excitability measured by transcranial magnetic stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuromuscular function : Peripheral function</measure>
    <time_frame>6 weeks post-discharge</time_frame>
    <description>Peripheral function by electrical nerve stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal oxygen uptake (VO2max)</measure>
    <time_frame>6 weeks post-discharge</time_frame>
    <description>measured by effort test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of sleep</measure>
    <time_frame>6 weeks post-discharge</time_frame>
    <description>measured by actigraphy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle volume</measure>
    <time_frame>6 weeks post-discharge</time_frame>
    <description>with Magnetic resonance imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>metabolic fatigue</measure>
    <time_frame>6 weeks post-discharge</time_frame>
    <description>measured by a Phosphorus 31 Nuclear magnetic resonance test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Chronic Fatigue Syndrome</condition>
  <condition>Intensive Care Unit</condition>
  <condition>Muscle</condition>
  <arm_group>
    <arm_group_label>&quot;Non-fatigued&quot; patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;Fatigued&quot; patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>Quality of life Depression Physical pain Social provisions Quality of sleep</description>
    <arm_group_label>&quot;Fatigued&quot; patients</arm_group_label>
    <arm_group_label>&quot;Non-fatigued&quot; patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood test</intervention_name>
    <description>complete blood count and cytokine concentration</description>
    <arm_group_label>&quot;Fatigued&quot; patients</arm_group_label>
    <arm_group_label>&quot;Non-fatigued&quot; patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Maximal effort test</intervention_name>
    <description>The maximal effort test with VO2max recordings will be assessed during the first visit to the laboratory.</description>
    <arm_group_label>&quot;Fatigued&quot; patients</arm_group_label>
    <arm_group_label>&quot;Non-fatigued&quot; patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>actigraphy</intervention_name>
    <description>assessment of sleep quality</description>
    <arm_group_label>&quot;Fatigued&quot; patients</arm_group_label>
    <arm_group_label>&quot;Non-fatigued&quot; patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuromuscular evaluation</intervention_name>
    <description>The maximum isometric force produced by the knee extensors will be measured on the ergometer
the intensity of muscular electrical activity recorded by surface electromyography
Peripheral nerve stimulation
Transcranial magnetic stimulation
Magnetic resonance imaging</description>
    <arm_group_label>&quot;Fatigued&quot; patients</arm_group_label>
    <arm_group_label>&quot;Non-fatigued&quot; patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with Covid-19

          -  Ventilated in ICU for at least 3 consecutive days

          -  ICU discharge between 4 and 8 weeks

          -  Approval received from a physician

          -  Command of the French language

        Exclusion Criteria:

          -  Taking neuroactive substances that can alter corticospinal excitability

          -  Patients with co-morbidities leading to significant fatigue: e.g. cancerous
             pathologies, sleep apnea

          -  Patients with neurodegenerative or neuromuscular disease

          -  Contraindication to the application of a magnetic field

          -  Contraindication to the practice of Magnetic Resonance Imaging

          -  Participant is pregnant

          -  Patients with psychiatric disorders

          -  Paraplegic and hemiplegic patients

          -  Addictive disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jérome MOREL, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint Etienne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jérome MOREL, MD PhD</last_name>
    <phone>0477828553</phone>
    <phone_ext>+33</phone_ext>
    <email>jerome.morel@chu-st-etienne.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre BOUZAT, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>Pierre BOUZAT, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renaud TAMISIER, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane DOUTRELEAU, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique de la Sauvegarde - Lyon</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier DESEBBE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Olivier DESEBBE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Croix Rousse - HCL</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Céline GUICHON, MD</last_name>
    </contact>
    <investigator>
      <last_name>Céline GUICHON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Saint-Etienne</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérome MOREL, MD PhD</last_name>
      <phone>(0)477828553</phone>
      <phone_ext>+33</phone_ext>
      <email>jerome.morel@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre CROISILLE, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Léonard FEASSON, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jérôme MOREL, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillaume THIERY, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascal GIRAUX, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lydia OUJAMAA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clément Foschia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marine Sorg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Mutualiste Saint Etienne</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincent GAUTHIER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Vincent GAUTHIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital privé de la Loire</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Laurent GERGELE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 24, 2020</study_first_submitted>
  <study_first_submitted_qc>April 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2020</study_first_posted>
  <last_update_submitted>June 8, 2020</last_update_submitted>
  <last_update_submitted_qc>June 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuromuscular function</keyword>
  <keyword>Fatigability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue Syndrome, Chronic</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

